4.5 Article

ReMixT: clone-specific genomic structure estimation in cancer

期刊

GENOME BIOLOGY
卷 18, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s13059-017-1267-2

关键词

Cancer genomics; DNA sequencing; Tumour heterogeneity; Genomic rearrangement; Copy number variation

资金

  1. Discovery Frontiers project grant
  2. Cancer Genome Collaboratory - Natural Sciences and Engineering Research Council (NSERC)
  3. Cancer Genome Collaboratory - Genome Canada (GC)
  4. Cancer Genome Collaboratory - Canadian Institutes of Health Research (CIHR)
  5. Cancer Genome Collaboratory - Canada Foundation for Innovation (CFI)
  6. BC Cancer Foundation
  7. Canadian Breast Cancer Foundation
  8. Canadian Cancer Society Research Institute [701584]
  9. Terry Fox Research Institute
  10. CIHR [MOP-115170]
  11. CIHR Foundation [FDN-143246]
  12. Canada Research Chairs
  13. NIH [GM108348]
  14. Indiana University Precision Health Grand Challenge Initiative

向作者/读者索取更多资源

Somatic evolution of malignant cells produces tumors composed of multiple clonal populations, distinguished in part by rearrangements and copy number changes affecting chromosomal segments. Whole genome sequencing mixes the signals of sampled populations, diluting the signals of clone-specific aberrations, and complicating estimation of clone-specific genotypes. We introduce ReMixT, a method to unmix tumor and contaminating normal signals and jointly predict mixture proportions, clone-specific segment copy number, and clone specificity of breakpoints. ReMixT is free, open-source software and is available at http://bitbucket.org/dranew/remixt.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据